Simplifying Global Compliance
FDA Withdraws Rule on Internal Research Misconduct Investigations
Washington Drug Letter
The FDA is withdrawing a direct final rule that exempted it from disclosing certain scientific research misconduct records on FDA staff or someone working on behalf of the agency.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing